|
CYTH3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.098100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.484000E-03 |
| Normal-vs-Stage2 |
2.926400E-01 |
| Normal-vs-Stage3 |
1.862370E-01 |
| Normal-vs-Stage4 |
1.038850E-01 |
| Stage1-vs-Stage2 |
5.293800E-01 |
| Stage1-vs-Stage3 |
7.561800E-01 |
| Stage1-vs-Stage4 |
6.219400E-01 |
| Stage2-vs-Stage3 |
7.893600E-01 |
| Stage2-vs-Stage4 |
3.852600E-01 |
| Stage3-vs-Stage4 |
5.753600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.217700E-03 |
| Normal-vs-AfricanAmerican |
5.463700E-02 |
| Normal-vs-Asian |
4.894200E-01 |
| Caucasian-vs-AfricanAmerican |
9.064400E-01 |
| Caucasian-vs-Asian |
9.854400E-01 |
| AfricanAmerican-vs-Asian |
9.539800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.864100E-03 |
| Normal-vs-Female |
2.671200E-01 |
| Male-vs-Female |
2.006800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.172300E-04 |
| Normal-vs-Extreme_Weight |
2.680000E-02 |
| Normal-vs-Obese |
3.990800E-01 |
| Normal-vs-Extreme_Obese |
3.348600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.250300E-02 |
| Normal_Weight-vs-Obese |
1.196280E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.946800E-01 |
| Extreme_Weight-vs-Obese |
2.851800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.696000E-01 |
| Obese-vs-Extreme_Obese |
5.115800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.858600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.767800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.356500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.066180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.416200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.481900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.190230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.081920E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.531800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.832000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.516770E-01 |
| Normal-VS-Type2 PRCC |
1.49140000016423E-07 |
| Normal-VS-KIRP CIMP |
2.085200E-01 |
| Normal-VS-Unclassified PRCC |
8.529800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.54539999966497E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.806200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.596200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.17640000002672E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
8.968900E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.664400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.392200E-04 |
| Normal-vs-N1 |
1.105630E-01 |
| Normal-vs-N2 |
5.321400E-01 |
| N0-vs-N1 |
3.532400E-01 |
| N0-vs-N2 |
3.834600E-01 |
| N1-vs-N2 |
7.306800E-01 |
|
|
